Histopathologic pitfalls in Mohs surgery can make it difficult to accurately identify cancer cells. Different skin cancers have unique cellular patterns that Mohs surgeons must carefully recognize under the microscope to ensure complete tumor removal.
Mohs micrographic surgery stands as the gold standard for treating many skin cancers, but what happens after the tissue is removed is equally critical to successful outcomes.
This article delves into the intricate world of histopathologic examination during Mohs surgery, exploring common challenges surgeons face when interpreting tissue samples and how they navigate these complexities to deliver optimal patient care.
Mohs micrographic surgery is a specialized technique for removing skin cancer that offers the highest cure rates while preserving as much healthy tissue as possible. What makes this procedure unique is its meticulous approach to cancer removal through real-time microscopic examination of the excised tissue. While most patients understand that Mohs surgery removes their skin cancer layer by layer, many are unaware of the sophisticated analysis happening behind the scenes.
The microscopic examination during Mohs surgery is where science and art converge. The surgeon not only removes the visible tumor but also acts as a pathologist, examining each tissue sample to ensure complete cancer removal before closing the wound. Despite its precision, this process faces several histopathologic challenges that require expertise and careful interpretation.
Understanding these "pitfalls" helps patients appreciate the thoroughness and complexity of the procedure they're undergoing. It's this microscopic detective work that makes Mohs surgery so effective, with cure rates exceeding 99% for many skin cancers.
Think of tissue processing as similar to preparing a special dish that needs to be examined closely before serving. Once your surgeon removes a layer of tissue, it begins a carefully orchestrated journey through the on-site Mohs laboratory.
First, the surgeon maps the tissue's orientation, creating a reference guide to pinpoint exactly where any remaining cancer cells might be located on your body. The sample is then divided into sections and color-coded, maintaining this critical spatial orientation throughout processing.
For the tissue to be examined under a microscope, it must be incredibly thin—about 5-7 micrometers, thinner than a human hair. To achieve this, the tissue is flash-frozen using a cryostat, a specialized freezing device. This freezing stabilizes the tissue, allowing it to be cut into these ultra-thin sections without distortion.
Unlike traditional pathology, which can take days because tissues are embedded in paraffin wax, this frozen section technique allows for rapid processing in about 20-30 minutes, enabling the surgeon to continue removing additional tissue if necessary during the same appointment.
The tissue sections, now mounted on glass slides, would be nearly invisible without staining. Histotechnicians apply special dyes—typically hematoxylin and eosin (H&E)—that highlight different cellular components.
These vibrant colors allow the Mohs surgeon to distinguish normal cells from cancerous ones based on their appearance, structure, and arrangement. Without proper staining, identifying cancer cells would be like trying to find a clear marble in a glass of water—virtually impossible.
Even with meticulous technique, several factors can complicate accurate histopathologic interpretation during Mohs surgery.
Physical manipulation of the delicate tissue can introduce distortions called artifacts. If the tissue is compressed, folded, or torn during processing, it can appear altered under the microscope. Imagine trying to identify a pattern on crumpled paper versus one that's smoothly laid out—the same challenge applies to distorted tissue samples.
The angle at which tissue is cut dramatically affects how cells appear under the microscope. Consider viewing a drinking straw—looking at it from the end shows a circle, while from the side it appears rectangular. Similarly, skin structures like hair follicles can look entirely different depending on the plane of sectioning. Basal cell carcinomas that infiltrate along follicular structures may be missed if sectioned at the wrong angle.
Materials used during surgery itself can sometimes contaminate slides. Electrocautery (used to control bleeding) can cause thermal artifacts that mimic certain cancer patterns. Local anesthetics, antiseptic solutions, or even tattooing inks can leave behind residues that complicate interpretation.
Quality control in the staining process is critical. If a slide is under-stained, cancer cells might be missed. If over-stained, normal structures might appear abnormal. Variations in pH, temperature, or staining duration can all affect how tissues appear, potentially leading to false interpretations if not properly recognized.
Mohs surgeons are searching for the visual signatures of different skin cancers, each with distinctive patterns and cellular characteristics.
The most common skin cancer has several histologic patterns that Mohs surgeons must recognize. Nodular BCC typically shows well-defined "islands" of abnormal cells with peripheral cells arranged like a picket fence (palisading) surrounding a darker center. Infiltrative or morpheaform BCC is more challenging to identify, appearing as thin strands of tumor cells that can easily be confused with normal structures like nerve or eccrine ducts.
SCC cells appear more mature than BCC cells and often form recognizable "keratin pearls" where cancer cells attempt to create normal skin structures. The cells look like spiky, irregular versions of normal squamous cells, with abnormally large nuclei and disorganized growth patterns. In poorly differentiated SCC, these recognizable features may be less evident, making identification more challenging.
When Mohs surgery is used for certain melanomas, surgeons look for characteristic pigmented cells with large, irregular nuclei. Special stains like MART-1 or Melan-A are often used to highlight these cells, as melanoma can sometimes be mistaken for inflammation or other benign conditions under standard H&E staining.
Some tumors, like dermatofibrosarcoma protuberans (DFSP), microcystic adnexal carcinoma, or sebaceous carcinoma, have subtle histologic features that can be especially challenging to distinguish from normal structures. These rare tumors often require specialized expertise and occasionally additional immunohistochemical stains for accurate identification.
Accuracy in Mohs surgery requires a coordinated team approach and multiple quality control measures.
From the moment tissue is removed, it's treated with extreme care. Surgeons use specialized tools and gentle technique to prevent crushing or distorting the sample. The mapping process is standardized and double-checked to ensure proper orientation.
Mohs laboratories follow strict standardized protocols for tissue processing. Variables like freezing temperature, section thickness, and staining times are carefully controlled. Many labs employ dedicated histotechnicians who specialize in Mohs procedures and understand the critical nature of their work.
Fellowship-trained Mohs surgeons complete additional training in histopathology, spending thousands of hours learning to recognize both normal skin structures and cancer patterns. This experience allows them to distinguish true cancer from misleading artifacts or mimickers.
When standard H&E staining yields ambiguous results, specialized immunohistochemical stains can highlight specific cell types. For example, cytokeratin stains can confirm the presence of carcinoma cells, while S-100 or SOX-10 may help identify melanoma.
In particularly challenging cases, Mohs surgeons may consult with colleagues or dermatopathologists. Many surgeons photograph difficult or unusual cases for future reference, building their pattern recognition abilities.
Mohs micrographic surgery represents the intersection of surgical precision and pathological expertise, with the microscopic examination serving as the critical bridge between cancer removal and complete cure. While histopathologic pitfalls exist, they're countered by rigorous training, standardized protocols, and the surgeon's accumulated experience.
The complexity behind interpreting tissue samples explains why Mohs surgery isn't just about excising visible tumors—it's about ensuring through microscopic confirmation that every cancer cell has been eliminated. This thorough approach allows Mohs surgery to achieve the highest cure rates while preserving maximum healthy tissue.
For patients at Dermatology & Skin Health under Dr. Gary Mendese's care, understanding these behind-the-scenes challenges highlights the level of expertise and attention to detail invested in their treatment. It's this commitment to microscopic precision that makes Mohs surgery not just a procedure, but a comprehensive approach to skin cancer care that leaves nothing to chance.
If your desired appointment type or preferred provider is unavailable online, kindly call (978) 525-0100 for Peabody, MA and (603) 742-5556 for all New Hampshire locations. Alternatively please feel free to send us your request via the patient portal, or via email at info@dermskinhealth.com
*For medical dermatology appointments in MA please dial (978) 525-0100 or fill out the appointment request form above.